Literature DB >> 17034409

Sexual function in women with urinary incontinence treated by pelvic floor transvaginal electrical stimulation.

Paradiso Galatioto Giuseppe1, Gianna Pace2, Carlo Vicentini1.   

Abstract

INTRODUCTION: Women's sexual dysfunctions (WSD) have been commonly associated with urinary incontinence (UI). Women with UI and who scored low on the Female Sexual Function Index (FSFI) showed an improvement in urinary leakage and also in their sexual life following treatment by transvaginal electrical stimulation (TES). AIMS: To determine the effects of TES in 37 women complaining of UI, of whom 23 also had WSD, and to compare the FSFI scores of women with UI and 43 women not affected by UI who underwent routine urologic evaluation.
METHODS: Thirty-seven women complaining of UI were evaluated by voiding diary and with FSFI before and after 3 months of TES. All had a urogynecologic evaluation and urodynamic study. MAIN OUTCOME MEASURES: In the voiding diary the women reported the types of liquid they ingested, urinary frequency, and episodes of urgency and urine leakage. The domain scores of the FSFI, including desire, arousal, lubrication, orgasm, satisfaction, and pain, were calculated. TES was conducted for 15-30 minutes, twice a week for 3 months, using biphasic intermittent current with a frequency of 50 Hz for stress UI (SUI) and 20 Hz for urge UI (UUI), and the most tolerable intensity of stimulation.
RESULTS: After TES, only two of the 10 women with UUI experienced a few leakage incidents; patients with SUI were completely dry during TES; and only three reported a few episodes of UI during intense activities. The five patients with mixed UI improved mainly as regards urgency. The FSFI scores of patients complaining of UI showed significantly lower desire and sexual satisfaction, and higher sexual pain than controls. After 3 months, the 23 women affected by WSD, of the 37 participants with UI, reported a remarkable improvement in their sexual life.
CONCLUSIONS: TES was found to be a safe and effective therapy for selected patients affected by mild to moderate UI. Because women with UI also complain of WSD compared with the general female population, an investigation of female sexuality is suggested for these patients.

Entities:  

Mesh:

Year:  2006        PMID: 17034409     DOI: 10.1111/j.1743-6109.2006.00318.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

1.  CUA guideline on adult overactive bladder.

Authors:  Jacques Corcos; Mikolaj Przydacz; Lysanne Campeau; Gary Gray; Duane Hickling; Christiane Honeine; Sidney B Radomski; Lynn Stothers; Adrian Wagg; Frcp Lond
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

Review 2.  Dysfunctional voiding: Challenges of disease transition from childhood to adulthood.

Authors:  Fannie Morin; Hamed Akhavizadegan; Alex Kavanagh; Katherine Moore
Journal:  Can Urol Assoc J       Date:  2018-04       Impact factor: 1.862

Review 3.  Stress urinary incontinence and LUTS in women--effects on sexual function.

Authors:  Brigitte Fatton; Renaud de Tayrac; Pierre Costa
Journal:  Nat Rev Urol       Date:  2014-09-09       Impact factor: 14.432

Review 4.  A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being.

Authors:  Valentina Lucia La Rosa; Alessio Platania; Michał Ciebiera; Simone Garzon; Robert Jędra; Marco Ponta; Salvatore Butticè
Journal:  Prz Menopauzalny       Date:  2019-06-28

5.  Effects of surface electrical stimulation during sitting on pelvic floor muscle function and sexual function in women with stress urinary incontinence.

Authors:  Ui-Jae Hwang; Oh-Yun Kwon; Min-Seok Lee
Journal:  Obstet Gynecol Sci       Date:  2020-03-30

6.  Effects of nonsurgical, minimally or noninvasive therapies for urinary incontinence due to neurogenic bladder: a systematic review and meta-analysis.

Authors:  Mohammed Usman Ali; Kenneth Nai-Kuen Fong; Priya Kannan; Umar Muhammad Bello; Georg Kranz
Journal:  Ther Adv Chronic Dis       Date:  2022-03-18       Impact factor: 5.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.